Funding Opportunities

[ LSOs | Intramural Awards | Foundations/Other | NIH Announcements ]

Intramural Funding Opportunities

• Deadline: June 5, 2023
  Prostate Cancer Program 2023 Research Pilot Awards
  The UCSF Prostate Cancer Program seeks to fund pilot projects in any area of prostate cancer research. All areas of prostate cancer research including computational, laboratory, translational, clinical, and population sciences are eligible. Please note that this is a call for primary research proposals, and the opportunity is not intended to support resource or infrastructure development. 
• Deadline: June 9, 2023
  2023-2024 UCSF-JMH Cancer Research Collaboration
  The UCSF-John Muir Health partnership is requesting project proposals for clinical research collaborations between UCSF main campus faculty and partners at UCSF-JMH Cancer Center in Berkeley or JMH Concord/Walnut Creek. Funding is intended to support collaboration of UCSF affiliate and UCSF main campus oncologists in investigator-initiated research studies. 
• Deadline: July 3, 2023
  DHART SPORE Developmental Research Program
  The Developmental Research Program (DRP) supports innovative pilot projects to advance the diagnosis and treatment of early stage tumors and advanced cancers characterized by germline and somatic NF1 mutations through rigorous translational research in the areas of population science, therapeutics, and mechanisms of disease and by facilitating collaborative interactions between DRP-funded scientists and other SPORE investigators. [UCSF contact: Kevin Shannon, MD]
• Deadline: July 3, 2023
  DHART SPORE Career Enhancement Program
  The goals of the Career Enhancement Program are: (1) to attract outstanding early stage basic, translational and clinical investigators to the field of NF1-assocaited tumor research; (2) to assist in the career development of these early stage faculty; and, (3) to encourage collaborations between investigators that can lead to new ideas and directions in research related to tumors associated with NF1 mutations while also contributing to career development. [UCSF contact: Kevin Shannon, MD]
• Deadline: rolling submissions
  University of California Hematologic Malignancies Consortium (UCHMC) RFA
  The University of California Hematologic Malignancies Consortium is requesting submission of proposals within two potential areas of funding.
  • RFP A: UCHMC funds for Junior Faculty and Trainee Competitive Seed Grants
  • RFP B: UCHMC funds for Clinical Trials Support

Foundations/Other Sources

• Deadline: June 7, 2023
  Victoria's Secret Global Fund for Women's Cancers Career Development Award (in partnership with Pelotonia and AACR)
  This program intends to fund innovative research projects in breast and gynecologic cancers and to invest in the next generation of female early-stage scientists domestically and globally. The aim of this award is to foster innovation in  the understanding, prevention, interception, early detection, diagnosis, and treatment of breast and gynecologic cancers with the goal of eliminating cancer health disparities and improving patient outcomes.
• Deadline: June 21, 2023
  AACR-Lung Cancer Initiative at Johnson & Johnson Stimulating Therapeutic Advances Through Research Training (START) Grant
  We invite postdoctoral and clinical fellows to apply for the AACR-Lung Cancer Initiative at Johnson & Johnson START Grant. This unique three-year, $225,000 grant will provide the opportunity for training and research in both academia and industry, while allowing recipients to spend one year at a Johnson & Johnson facility. Applicants must be female or belong to one of the following underrepresented groups as per NIH guidelines, and the research proposal must have direct applicability to lung cancer.  Potential applicants may reach out to the HDFCCC Office of DEIA for help with the application process (email [email protected]).
• Deadline: June 22, 2023
  NCI-Cancer Research UK Cancer Grand Challenges
  Cancer Grand Challenges aims to provide multiple rounds of funding for interdisciplinary research teams from around the world whose novel ideas offer the greatest potential to advance bold cancer research and improve outcomes for people affected by cancer. In this round, nine challenges were developed through a series of international workshops and an open call online that collected ideas from the cancer research community and people affected by cancer.